These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37309826)

  • 1. Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities.
    Wang L; Li C; Li W; Zhao L; Zhao T; Chen L; Li M; Fan J; Li J; Wu C; Chen Y
    Emerg Microbes Infect; 2023 Dec; 12(2):2225640. PubMed ID: 37309826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients.
    Chen Y; Zhao T; Chen L; Jiang G; Geng Y; Li W; Yin S; Tong X; Tao Y; Ni J; Lu Q; Ning M; Wu C
    mBio; 2024 Apr; 15(4):e0240723. PubMed ID: 38456703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced neutralization and Fc effector function to Omicron subvariants in sera from SARS-CoV-1 survivors after two doses of CoronaVac plus one dose subunit vaccine.
    Chen D; Li X; Hao X; Qiu Y; Song Y; Sun H; Liu Y; Du J; Zhang Y; Xiao F; Song C; Yan Y; Song R; Wang X; Zhao X; Jin R
    J Med Virol; 2023 Oct; 95(10):e29136. PubMed ID: 37804496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages.
    Guo L; Zhang Q; Zhong J; Chen L; Jiang W; Huang T; Li Y; Zhang Y; Xu L; Wang X; Xiao Y; Wang Y; Dong X; Dong T; Peng Y; Zhang B; Xie Y; Gao H; Shen Z; Ren L; Cheng T; Wang J
    Emerg Microbes Infect; 2023 Dec; 12(1):2202263. PubMed ID: 37037791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing activity of a third dose of CoronaVac against Omicron subvariants within a 20-month follow-up study.
    Cao C; Guo Q; Dai Y; Jiang J; Liu M; Ji T; Zhou P; Gong F
    Hum Vaccin Immunother; 2023 Aug; 19(2):2242217. PubMed ID: 37529941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein.
    Hong Y; Guo H; Wei M; Zhang Y; Fang M; Cheng T; Li Z; Ge S; Yao X; Yuan Q; Xia N
    J Virol Methods; 2022 Sep; 307():114564. PubMed ID: 35671888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals.
    Richardson SI; Madzorera VS; Spencer H; Manamela NP; van der Mescht MA; Lambson BE; Oosthuysen B; Ayres F; Makhado Z; Moyo-Gwete T; Mzindle N; Motlou T; Strydom A; Mendes A; Tegally H; de Beer Z; Roma de Villiers T; Bodenstein A; van den Berg G; Venter M; de Oliviera T; Ueckermann V; Rossouw TM; Boswell MT; Moore PL
    Cell Host Microbe; 2022 Jun; 30(6):880-886.e4. PubMed ID: 35436444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of humoral immune responses induced by a 3-dose inactivated COVID-19 vaccine in an observational, prospective cohort.
    Tao Y; Ma M; Hu F; Li M; Geng Y; Wan Y; Mao M; Chen L; Shen Y; Zhu L; Shen H; Chen Y
    BMC Immunol; 2022 Nov; 23(1):57. PubMed ID: 36384440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.
    Mok CKP; Chen C; Zhao S; Sun Y; Yiu K; Chan TO; Lai HL; Lai KC; Lau KM; Ling KC; Chan KKP; Ng SS; Ko FW; Peiris M; Hui DS
    Lancet Microbe; 2023 Jun; 4(6):e418-e430. PubMed ID: 37086735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.
    Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C
    Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose.
    Filardi BA; Monteiro VS; Schwartzmann PV; do Prado Martins V; Zucca LER; Baiocchi GC; Malik AA; Silva J; Hahn AM; Chen NFG; Pham K; Pérez-Then E; Miric M; Brache V; Cochon L; Larocca RA; Mendez RDR; Bardini Silveira D; Pinto AR; Croda J; Yildirim I; Omer SB; Ko AI; Vermund SH; Grubaugh ND; Iwasaki A; Lucas C; ; Vogels CBF; Breban M; Koch TR; Chaguza C; Tikhonova I; Castaldi C; Mane S; De Kumar B; Ferguson D; Kerantzas N; Peaper D; Landry ML; Schulz W
    Sci Transl Med; 2023 Feb; 15(683):eade6023. PubMed ID: 36791210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants.
    Wang XJ; Yao L; Zhang HY; Zhu KL; Zhao J; Zhan BD; Li YK; He XJ; Huang C; Wang ZY; Jiang MD; Yang P; Yang Y; Wang GL; Wang SQ; Dai EH; Gao HX; Ma MJ
    Genome Med; 2022 Dec; 14(1):146. PubMed ID: 36581867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals.
    Sembera J; Baine C; Ankunda V; Katende JS; Oluka GK; Akoli CH; Kato L; Odoch G; Ejou P; Opio S; Musenero M; ; Kaleebu P; Serwanga J
    Front Immunol; 2023; 14():1255676. PubMed ID: 38098482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination.
    Tong X; McNamara RP; Avendaño MJ; Serrano EF; García-Salum T; Pardo-Roa C; Bertera HL; Chicz TM; Levican J; Poblete E; Salinas E; Muñoz A; Riquelme A; Alter G; Medina RA
    Nat Commun; 2023 Jul; 14(1):4174. PubMed ID: 37443074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection.
    Brady T; Cayatte C; Roe TL; Speer SD; Ji H; Machiesky L; Zhang T; Wilkins D; Tuffy KM; Kelly EJ
    Front Immunol; 2023; 14():1283120. PubMed ID: 37901217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection.
    Zhu KL; Jiang XL; Zhan BD; Wang XJ; Xia X; Cao GP; Sun WK; Huang PX; Zhang JZ; Gao YL; Dai EH; Gao HX; Ma MJ
    Cell Rep; 2023 Feb; 42(2):112075. PubMed ID: 36774551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses.
    Tay MZ; Wiehe K; Pollara J
    Front Immunol; 2019; 10():332. PubMed ID: 30873178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection.
    Vangeti S; Periasamy S; Sun P; Balinsky CA; Mahajan AS; Kuzmina NA; Soares-Schanoski A; Cooper E; Beckett C; Marayag J; Marrone A; Nunez E; Ge Y; Porter CK; Goforth CW; Lizewski SE; Lizewski R; Jani V; Sugiharto VA; Schilling M; Yu XB; Marjanovic N; George MC; Bukreyev A; Sealfon SC; Letizia AG; Ramos I
    Microbiol Spectr; 2022 Dec; 10(6):e0183722. PubMed ID: 36374040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study.
    Hua Q; Zhang H; Yao P; Xu N; Sun Y; Lu H; Xu F; Liao Y; Yang J; Mao H; Zhang Y; Zhu H; Hu X; Lv H; Jiang J
    Front Immunol; 2022; 13():939311. PubMed ID: 36032136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults.
    Li T; Luo D; Ning N; Wang X; Zhang L; Yang X; Li D; Sun Y; Yu W; Wei W; Wang H
    Emerg Microbes Infect; 2023 Dec; 12(1):2207670. PubMed ID: 37272331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.